+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Isothermal Nucleic Acid Amplification Technology Market by Product, Type, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5533363
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Isothermal Nucleic Acid Amplification Technology Market grew from USD 3.77 billion in 2023 to USD 4.25 billion in 2024. It is expected to continue growing at a CAGR of 13.64%, reaching USD 9.22 billion by 2030.

Isothermal Nucleic Acid Amplification Technology (INAAT) represents an advanced method of amplifying DNA and RNA in molecular biology and diagnostics, eliminating the need for thermal cycling found in traditional polymerase chain reactions (PCR). This technology is crucial for rapid, sensitive, and point-of-care diagnostics owing to its simplicity and efficiency. INAAT's necessity arises from the growing demand for quick diagnostic tools, especially amid infectious disease outbreaks, enabling real-time decision-making in clinical settings. Applications span across varied sectors, including healthcare diagnostics for infectious and genetic diseases, veterinary medicine, agriculture for pathogen detection, and environmental monitoring. The end-use scope involves hospitals, diagnostic laboratories, research institutions, and point-of-care testing centers. Market insights reveal that increased incidences of infectious diseases, technological advancements, and a surge in demand for rapid diagnostics are key growth drivers. Opportunities lie in the development of portable, user-friendly diagnostic devices catering to remote and resource-limited areas, which can capture a broader customer base. Nonetheless, market growth faces challenges such as the high cost of INAAT equipment, limited awareness in developing regions, and competition from established PCR technologies. Measures like strategic collaborations, government funding, and industry partnerships can aid in overcoming these barriers. Innovation in the field can focus on enhancing assay sensitivity, reducing costs, and automating processes for wider adoption. Research into multiplexing capabilities can offer more comprehensive diagnostic solutions, thus enticing market players to invest. Additionally, integrating digital health technologies could expand monitoring capabilities through connected devices. The market is characterized by rapid technological evolution and a competitive landscape, necessitating continuous innovation in assay development and distribution strategies to maintain relevance and competitive advantage. Hence, stakeholders are recommended to invest in education and training to increase awareness and familiarity with INAAT, explore developing markets, and focus on personalized diagnostic solutions.

Understanding Market Dynamics in the Isothermal Nucleic Acid Amplification Technology Market

The Isothermal Nucleic Acid Amplification Technology Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of antimicrobial and infectious diseases worldwide
    • Increasing adoption of INAAT for accurate & rapid testing results
    • Development of miniaturized nucleic acid-based diagnostics
  • Market Restraints
    • High cost of reagents and implementation of technology
  • Market Opportunities
    • Technological advancements in isothermal nucleic acid amplification
    • Increasing adoption of digital diagnostics and rising demand for point-of-care diagnostics solutions
  • Market Challenges
    • Limitation of isothermal nucleic acid amplification technology

Exploring Porter’s Five Forces for the Isothermal Nucleic Acid Amplification Technology Market

Porter’s Five Forces framework further strengthens the insights of the Isothermal Nucleic Acid Amplification Technology Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Isothermal Nucleic Acid Amplification Technology Market

External macro-environmental factors deeply influence the performance of the Isothermal Nucleic Acid Amplification Technology Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Isothermal Nucleic Acid Amplification Technology Market

The Isothermal Nucleic Acid Amplification Technology Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Isothermal Nucleic Acid Amplification Technology Market

The Isothermal Nucleic Acid Amplification Technology Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Isothermal Nucleic Acid Amplification Technology Market

The Isothermal Nucleic Acid Amplification Technology Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Isothermal Nucleic Acid Amplification Technology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AtilaBiosystems, Beijing SBS Genetech Co., Ltd., bioMérieux SA, Biosearch Technologies by LGC Limited, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Fortis Life Sciences, LLC, GENOMTEC S.A., GenoSensor Corporation, Grifols S.A., highQu GmbH, Hologic, Inc., Illumina, Inc., Jena Bioscience GmbH, Life Sciences Advanced Technologies, Inc., Mast Group Ltd., Meridian Bioscience Inc. by SD Biosensor, Inc., New England Biolabs, Inc., OptiGene Limited, PCR Biosystems Ltd., QIAGEN GmbH, Quidel Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Ustar Biotechnologies (Hangzhou) Ltd, Xiamen Jiqing Biomedical Technology Co., Ltd., Zhengzhou Laboao Instrument Equipment CO., LTD, and Zhuhai Biori Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Isothermal Nucleic Acid Amplification Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Assays, Kits, & Reagents
    • Systems
  • Type
    • Helicase-dependent Amplification
    • Loop-mediated Isothermal Amplification
    • Nucleic Acid Sequence-based Amplification
    • Strand Displacement Amplification
    • Transcription-mediated Amplification
  • Application
    • Blood Screening
    • Disease Diagnosis
      • CT/NG
      • Hepatitis
      • HIV
      • Influenza
  • End-User
    • Academic & Research Institutes
    • Hospitals
    • Reference Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of antimicrobial and infectious diseases worldwide
5.1.1.2. Increasing adoption of INAAT for accurate & rapid testing results
5.1.1.3. Development of miniaturized nucleic acid-based diagnostics
5.1.2. Restraints
5.1.2.1. High cost of reagents and implementation of technology
5.1.3. Opportunities
5.1.3.1. Technological advancements in isothermal nucleic acid amplification
5.1.3.2. Increasing adoption of digital diagnostics and rising demand for point-of-care diagnostics solutions
5.1.4. Challenges
5.1.4.1. Limitation of isothermal nucleic acid amplification technology
5.2. Market Segmentation Analysis
5.2.1. Product: Advancements in isothermal nucleic acid amplification technology systems to scale up their operations and automate their workflows
5.2.2. Type: Growing preference for transcription-mediated amplification in clinical diagnostics for its rapid and high amplification capacity
5.2.3. Application: Extensive utilization of isothermal nucleic acid amplification technology for disease diagnoses for promoting better patient outcomes
5.2.4. End-User: Significant role of isothermal nucleic acid amplification technology in hospitals for rapid and accurate diagnostics to improve patient care
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Isothermal Nucleic Acid Amplification Technology Market, by Product
6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Systems
7. Isothermal Nucleic Acid Amplification Technology Market, by Type
7.1. Introduction
7.2. Helicase-dependent Amplification
7.3. Loop-mediated Isothermal Amplification
7.4. Nucleic Acid Sequence-based Amplification
7.5. Strand Displacement Amplification
7.6. Transcription-mediated Amplification
8. Isothermal Nucleic Acid Amplification Technology Market, by Application
8.1. Introduction
8.2. Blood Screening
8.3. Disease Diagnosis
9. Isothermal Nucleic Acid Amplification Technology Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals
9.4. Reference Laboratories
10. Americas Isothermal Nucleic Acid Amplification Technology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Polish biotech Genomtec raises EUR 2.9 million (USD 3.19 million) from share issue
13.3.2. Stilla Technologies and Atila BioSystems to Co-Develop High-Plex Digital PCR Kits for Oncology
13.3.3. Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics
13.3.4. Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
13.3.5. Ankur Capital invests in molecular diagnostic startup D-NOME
13.3.6. WeTrade and Jiqing Biomedical partner to sell monkeypox tests
13.3.7. Recombinase Polymerase Amplification, or RPA, is the breakthrough, isothermal replacement to PCR
13.3.8. Mawi iSWAB Microbiome-EL Enables Prime Discoveries’ Development of Rapid Extraction-Less COVID Diagnostic Assay
13.3.9. Thermo Fisher introduces two RT-LAMP tests to detect viral pathogens
13.3.10. Medix Biochemica Acquires German MDx Raw Materials Producer MyPols Biotec
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET DYNAMICS
FIGURE 7. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE-DEPENDENT AMPLIFICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE-DEPENDENT AMPLIFICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CT/NG, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CT/NG, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HEPATITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HIV, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HIV, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFLUENZA, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 88. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 89. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 90. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 91. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 92. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 93. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 94. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 95. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 98. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 99. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 142. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 143. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 146. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 147. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 148. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 149. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 152. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 153. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 165. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 166. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 167. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 168. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 169. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 172. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 173. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 232. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 233. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 257. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 258. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 259. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 264. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 265. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. EGYPT ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE

Companies Mentioned

The leading players in the Isothermal Nucleic Acid Amplification Technology market, which are profiled in this report, include:
  • Abbott Laboratories
  • AtilaBiosystems
  • Beijing SBS Genetech Co., Ltd.
  • bioMérieux SA
  • Biosearch Technologies by LGC Limited
  • DiaSorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • Fortis Life Sciences, LLC
  • GENOMTEC S.A.
  • GenoSensor Corporation
  • Grifols S.A.
  • highQu GmbH
  • Hologic, Inc.
  • Illumina, Inc.
  • Jena Bioscience GmbH
  • Life Sciences Advanced Technologies, Inc.
  • Mast Group Ltd.
  • Meridian Bioscience Inc. by SD Biosensor, Inc.
  • New England Biolabs, Inc.
  • OptiGene Limited
  • PCR Biosystems Ltd.
  • QIAGEN GmbH
  • Quidel Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Ustar Biotechnologies (Hangzhou) Ltd
  • Xiamen Jiqing Biomedical Technology Co., Ltd.
  • Zhengzhou Laboao Instrument Equipment CO., LTD
  • Zhuhai Biori Biotechnology Co., Ltd.

Methodology

Loading
LOADING...

Table Information